Proteomics International Laboratories (PIQ.AX) Stock Price
Proteomics International Laboratories Price
Revenue at Proteomics International Laboratories has contracted by 5.3% per year over the past 14 years to 278,015.00 AUD. Proteomics International Laboratories's net margin stands at -3,078.9%, down from -333.9% several years earlier. Analysts set a median price target of 0.44 AUD, implying 265.5% above the current price. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.
Proteomics International Laboratories stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Proteomics International Laboratories business model & stock analysis
Frequently asked questions about Proteomics International Laboratories
Analysts currently set an average price target of 0.44 AUD for the Proteomics International Laboratories stock (median: 0.44 AUD), implying +265.5 % versus the latest price. The consensus is based on 7 analyst ratings.
Proteomics International Laboratories Analyst Price Targets 2026
7 analysts currently rate the Proteomics International Laboratories stock: 0 recommend buying, 3 holding and 4 selling.
Proteomics International Laboratories Analyst Price Targets 2026
Converted at the current exchange rate, the Proteomics International Laboratories share trades at 0.08 EUR (0.12 AUD).
The Proteomics International Laboratories share (PIQ.AX) is listed on 1 stock exchanges, including: ASX (PIQ.AX).
The revenue of Proteomics International Laboratories is 278,015.00 AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Proteomics International Laboratories is -8.56 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Proteomics International Laboratories is currently -1.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Proteomics International Laboratories stock.
The price-to-sales ratio (P/S) of Proteomics International Laboratories is currently 50.87. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Proteomics International Laboratories stock.
The Eulerpool Quality Score for Proteomics International Laboratories is 1/10.
The ISIN of Proteomics International Laboratories is AU000000PIQ0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Proteomics International Laboratories is PIQ.AX. The ticker symbol is used to trade Proteomics International Laboratories shares on the stock exchange.
Proteomics International Laboratories stock
Proteomics International Laboratories Peer Group
Proteomics International Laboratories Ticker
Proteomics International Laboratories FIGI
All fundamentals and in-depth analysis of Proteomics International Laboratories
Our stock analysis for Proteomics International Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Proteomics International Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.